NO892617L - Anti-aterogene midler. - Google Patents

Anti-aterogene midler.

Info

Publication number
NO892617L
NO892617L NO89892617A NO892617A NO892617L NO 892617 L NO892617 L NO 892617L NO 89892617 A NO89892617 A NO 89892617A NO 892617 A NO892617 A NO 892617A NO 892617 L NO892617 L NO 892617L
Authority
NO
Norway
Prior art keywords
aterogenic
agents
aterogenic agents
Prior art date
Application number
NO89892617A
Other languages
English (en)
Other versions
NO892617D0 (no
Inventor
Andries Johannes Corne Strydom
Original Assignee
Andries Johannes Corne Strydom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andries Johannes Corne Strydom filed Critical Andries Johannes Corne Strydom
Publication of NO892617D0 publication Critical patent/NO892617D0/no
Publication of NO892617L publication Critical patent/NO892617L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO89892617A 1988-06-24 1989-06-23 Anti-aterogene midler. NO892617L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA884556 1988-06-24

Publications (2)

Publication Number Publication Date
NO892617D0 NO892617D0 (no) 1989-06-23
NO892617L true NO892617L (no) 1989-12-27

Family

ID=25579302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892617A NO892617L (no) 1988-06-24 1989-06-23 Anti-aterogene midler.

Country Status (8)

Country Link
EP (1) EP0347864A3 (no)
JP (1) JPH0267216A (no)
AU (2) AU3673789A (no)
DK (1) DK313989A (no)
IL (1) IL90732A0 (no)
MC (1) MC2041A1 (no)
NO (1) NO892617L (no)
NZ (1) NZ229670A (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015750A1 (en) * 1993-12-10 1995-06-15 Hashim Sami A Reducing likelihood of vascular disorders in susceptible patients
EP0679394B1 (en) * 1994-04-28 1998-01-14 Eisai Co., Ltd. Menatetronome derivative as antiarteriosclerotic agent
WO1996031206A2 (en) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
DE19538666A1 (de) * 1995-10-17 1997-04-24 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von arteriellen Verschlußkrankheiten, Mikroangiopathien und Mikrozirkulationsstörungen
US6025369A (en) * 1996-05-03 2000-02-15 The Board Of Regents Of The University Nebraska N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
KR100213895B1 (ko) * 1996-10-14 1999-08-02 박원훈 감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
EP0983062A4 (en) 1997-05-21 2002-10-23 Sloan Kettering Inst Cancer METHOD FOR INCREASING THE CONCENTRATION OF ASCOBIC ACID IN PERSONAL BRAIN TISSUE
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
CA2307890A1 (en) * 1997-10-28 1999-05-06 Jun-Sung Lee Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
BR9914815A (pt) * 1998-10-30 2001-07-03 Merck Patent Gmbh Composições para tratamento e prevenção de doenças cardiovasculares
AU6202299A (en) * 1998-10-30 2000-05-22 Merck Patent Gmbh Compositions for the treatment and prevention of neurological and pathopsychological diseases
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (fr) * 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
CN1159984C (zh) * 1999-06-29 2004-08-04 新西兰奶制品研究所有限公司 基于奶的预防性饮食添加剂
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
JP5080011B2 (ja) * 2005-02-28 2012-11-21 第一三共ヘルスケア株式会社 グルタチオンペルオキシダーゼ活性を増加させるための組成物
JP2009506978A (ja) 2005-04-27 2009-02-19 メッサデク ジャアル インスリン類の併用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197284A (en) * 1981-05-29 1982-12-03 Eiichi Suenaga Alpha-tocopheryl nicotinate metal complex, its preparation, and remedy for arteriosclerosis comprising it as active ingredient

Also Published As

Publication number Publication date
IL90732A0 (en) 1990-01-18
MC2041A1 (fr) 1990-05-30
AU2999192A (en) 1993-02-04
NZ229670A (en) 1992-07-28
DK313989D0 (da) 1989-06-23
EP0347864A3 (en) 1992-04-01
AU3673789A (en) 1990-01-04
NO892617D0 (no) 1989-06-23
DK313989A (da) 1989-12-25
EP0347864A2 (en) 1989-12-27
JPH0267216A (ja) 1990-03-07

Similar Documents

Publication Publication Date Title
FI890234A0 (fi) Individuellt justerbart kuddsystem.
FI883650A (fi) Lastpresenning.
FI891841A0 (fi) Automatisk spraydosa.
DE68921898D1 (de) Ringbinder.
FI882967A (fi) Sprundfat.
DE58904437D1 (de) Rakelfarbwerk.
NO892617D0 (no) Anti-aterogene midler.
FI884174A0 (fi) Arrangemang foer materialundersoekning.
FI884167A0 (fi) Laosmekanism foer faellbar sittmoebel.
FI890476A (fi) Haollare foer braenslepelare utnyttjande en radiellt komprimerad fjaeder.
FI890087A (fi) Termostatisk blandningsventil.
NO893141D0 (no) Toey-kondisjoneringsmidler.
FI890496A (fi) Dubbelvira-pappersmaskins vaota aenda.
NO890554D0 (no) Roeykkanalsystem.
FI882036A (fi) Eluppvaermningselement.
FI881246A (fi) Loksnoeplog.
FI885119A0 (fi) Matningsanordning.
DE68905146D1 (de) Indanderivate.
FI890632A0 (fi) Laogtrycksupphettare foer vatten.
DE68907005D1 (de) Octafluorbiphenyle.
ES1006543Y (es) Muneco equilibrista.
FI885647A0 (fi) Flexibelt frontparti foer slaepkaerra.
FI880647A (fi) Reglersystem foer en harvs arbetsdjup.
FI911612A0 (fi) Korskopplingsstativ.
FI885433A0 (fi) Skidhandske.